<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the relationship between some thrombophilic parameters and pregnancy induced <z:hpo ids='HP_0000822'>hypertension</z:hpo> (PIH) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The study took place at the Department of Obstetrics and Gynecology, Perinatology Unit, Faculty of Medicine, Cukurova University, Turkey, between January 2002 and December 2002 </plain></SENT>
<SENT sid="2" pm="."><plain>We evaluated 202 patients </plain></SENT>
<SENT sid="3" pm="."><plain>Patients were divided into 2 groups: control group comprised 102 normotensive patients &gt;20 weeks of pregnancy without any medical or pregnancy related pathologies and the study group comprised 100 patients over 20 weeks of pregnancy with PIH </plain></SENT>
<SENT sid="4" pm="."><plain>These hypertensive patients were divided into 6 sub-groups as follows: <z:hpo ids='HP_0100601'>eclampsia</z:hpo>, <z:e sem="disease" ids="C0341950,C0156669" disease_type="Disease or Syndrome" abbrv="">severe preeclampsia</z:e>, <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e>, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0000822'>hypertension</z:hpo> plus <z:e sem="disease" ids="C0341931" disease_type="Disease or Syndrome" abbrv="">superimposed preeclampsia</z:e>, <z:hpo ids='HP_0100601'>eclampsia</z:hpo>, and <z:mp ids='MP_0010163'>hemolysis</z:mp> <z:hpo ids='HP_0002910'>elevated liver enzymes</z:hpo> and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HELLP</z:e>) syndrome </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: In <z:hpo ids='HP_0000001'>all</z:hpo> cases, complete blood count, antithrombin III, protein S levels, <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e>, prothrombin 20210 mutation, <z:chebi fb="0" ids="25297">methylenetetrahydrofolate</z:chebi> reductase (MTHFR) 677 mutation and <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels were studied </plain></SENT>
<SENT sid="6" pm="."><plain>Statistical analysis of the data was carried out using SPSS version 11.0 program </plain></SENT>
<SENT sid="7" pm="."><plain>In comparing the 2 groups we used Mann-Whitney U tests </plain></SENT>
<SENT sid="8" pm="."><plain>In comparing the PIH subgroups we used Kruskal-Wallis tests </plain></SENT>
<SENT sid="9" pm="."><plain>The levels of p&lt;0.05 were accepted as statistically significant </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: <z:hpo ids='HP_0001976'>Antithrombin III deficiency</z:hpo>, <z:hpo ids='HP_0005543'>protein C deficiency</z:hpo>, hyperhomocysteinanemia were found to be associated with PIH groups </plain></SENT>
<SENT sid="11" pm="."><plain>But <z:e sem="disease" ids="C0242666" disease_type="Disease or Syndrome" abbrv="">protein S deficiency</z:e>, and homozygote <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e>, prothrombin 20210, MTHFR 677 mutation were not found to be related with PIH </plain></SENT>
</text></document>